Bristol Prepares For Life After Pravachol: Support Will Continue Into 2005

Bristol-Myers Squibb will continue to promote Pravachol over the near term despite declining sales for the statin as wholesalers prepare for generic competition in 2006

More from Archive

More from Pink Sheet